1
|
Song W, Yao Y, Zhang H, Hao X, Zhou L, Song Z, Wei T, Chi T, Liu P, Ji X, Zou L. Sigma-1 Receptor Activation Improves Oligodendrogenesis and Promotes White-Matter Integrity after Stroke in Mice with Diabetic Mellitus. MOLECULES (BASEL, SWITZERLAND) 2023; 28:molecules28010390. [PMID: 36615583 PMCID: PMC9823930 DOI: 10.3390/molecules28010390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 12/26/2022] [Accepted: 12/29/2022] [Indexed: 01/04/2023]
Abstract
Diabetes mellitus (DM) is a major risk factor for stroke and exacerbates white-matter damage in focal cerebral ischemia. Our previous study showed that the sigma-1 receptor agonist PRE084 ameliorates bilateral common-carotid-artery occlusion-induced brain damage in mice. However, whether this protective effect can extend to white matter remains unclear. In this study, C57BL/6 mice were treated with high-fat diets (HFDs) combined with streptozotocin (STZ) injection to mimic type 2 diabetes mellitus (T2DM). Focal cerebral ischemia in T2DM mice was established via injection of the vasoconstrictor peptide endothelin-1 (ET-1) into the hippocampus. Three different treatment plans were used in this study. In one plan, 1 mg/kg of PRE084 (intraperitoneally) was administered for 7 d before ET-1 injection; the mice were sacrificed 24 h after ET-1 injection. In another plan, PRE084 treatment was initiated 24 h after ET-1 injection and lasted for 7 d. In the third plan, PRE084 treatment was initiated 24 h after ET-1 injection and lasted for 21 d. The Y-maze, novel object recognition, and passive avoidance tests were used to assess neurobehavioral outcomes. We found no cognitive dysfunction or white-matter damage 24 h after ET-1 injection. However, 7 and 21 d after ET-1 injection, the mice showed significant cognitive impairment and white-matter damage. Only PRE084 treatment for 21 d could improve this white-matter injury; increase axon and myelin density; decrease demyelination; and increase the expressions of myelin regulator 2'-3'-cyclic nucleotide 3'-phosphodiesterase (CNpase) and myelin oligodendrocyte protein (MOG) (which was expressed by mature oligodendrocytes), the number of nerve/glial-antigen 2 (NG2)-positive cells, and the expression of platelet-derived growth factor receptor-alpha (PDGFRα), all of which were expressed by oligodendrocyte progenitor cells in mice with diabetes and focal cerebral ischemia. These results indicate that maybe there was more severe white-matter damage in the focal cerebral ischemia of the diabetic mice than in the mice with normal blood glucose levels. Long-term sigma-1 receptor activation may promote oligodendrogenesis and white-matter functional recovery in patients with stroke and with diabetes.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Peng Liu
- Correspondence: (P.L.); (X.J.); (L.Z.); Tel.: +86-24-23986260 (P.L.)
| | - Xuefei Ji
- Correspondence: (P.L.); (X.J.); (L.Z.); Tel.: +86-24-23986260 (P.L.)
| | - Libo Zou
- Correspondence: (P.L.); (X.J.); (L.Z.); Tel.: +86-24-23986260 (P.L.)
| |
Collapse
|
2
|
Finney CA, Shvetcov A, Westbrook RF, Morris MJ, Jones NM. Tamoxifen offers long-term neuroprotection after hippocampal silent infarct in male rats. Horm Behav 2021; 136:105085. [PMID: 34749277 DOI: 10.1016/j.yhbeh.2021.105085] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/28/2020] [Revised: 10/21/2021] [Accepted: 10/22/2021] [Indexed: 11/19/2022]
Abstract
Silent infarcts (SI) are a cerebral small vessel disease characterized by small subcortical infarcts. These occur in the absence of typical ischemia symptoms but are linked to cognitive decline and dementia. While there are no approved treatments for SI, recent results from our laboratory suggest that tamoxifen, a selective estrogen receptor modulator, is a viable candidate. In the present study, we induced SI in the dorsal hippocampal CA1 region of rats and assessed the effects of systemic administration of tamoxifen (5 mg/kg, twice) 21 days after injury on cognitive and pathophysiological measures, including cell loss, apoptosis, gliosis and estrogen receptors (ERs). We found that tamoxifen protected against the SI-induced cognitive dysfunction on the hippocampal-dependent, place recognition task, cell and ER loss, and increased apoptosis and gliosis in the CA1. Exploratory data analyses using a scatterplot matrix and principal component analysis indicated that SI-tamoxifen rats were indistinguishable from sham controls while they differed from SI rats, who were characterized by enhanced cell loss, apoptosis and gliosis, lower ERs, and recognition memory deficit. Supervised machine learning using support vector machine (SVM) determined predictors of progression from the early ischemic state to the dementia-like state. It showed that caspase-3 and ERα in the CA1 and exploration proportion were reliable and accurate predictors of this progression. Importantly, tamoxifen ameliorated SI-induced effects on all three of these variables, providing further evidence for its viability as a candidate treatment for SI and prevention of associated dementia.
Collapse
|
3
|
Finney CA, Morris MJ, Westbrook RF, Jones NM. Hippocampal silent infarct leads to subtle cognitive decline that is associated with inflammation and gliosis at twenty-four hours after injury in a rat model. Behav Brain Res 2020; 401:113089. [PMID: 33358919 DOI: 10.1016/j.bbr.2020.113089] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2020] [Revised: 11/17/2020] [Accepted: 12/14/2020] [Indexed: 01/31/2023]
Abstract
Silent infarcts (SI) are subcortical cerebral infarcts that occur in the absence of clinical symptoms commonly associated with ischemia and are linked to dementia development. Little is known about the pathophysiology underlying the cognitive dysfunction associated with SI, and few studies have examined the early cellular responses and neurobiological underpinnings. We induced SI in adult male Sprague-Dawley rats using an infusion of endothelin-1 in the CA1 dorsal hippocampus. Twenty-four hours later, we assessed cognition using the hippocampal-dependent object place recognition task. We also examined whether the resulting cognitive effects were associated with common markers of ischemia, specifically cell and synapse loss, gliosis, and inflammation, using histology and immunohistochemistry. Hippocampal SI led to subtle cognitive impairment on the object place recognition task 24 -hs post-injury. This was characterized by a significant difference in exploration proportion relative to a pre-injury baseline and a positive association between time spent with both the moved and unmoved objects. SI did not result in any detectable cell or synaptophysin loss, but did increase apoptosis, gliosis and inflammation in the CA1. Principal component analysis indicated the main variables associated with hippocampal SI included increased time spent with the unmoved object, gliosis, apoptosis and inflammation as well as decreased exploration proportion and CA1 cells. Our data demonstrate that hippocampal SI can lead to cognitive dysfunction 24 -hs after injury. Further, this appears to be driven by early degenerative processes including apoptosis, gliosis and inflammation, suggesting that these may be targets for early interventions treating hippocampal SI and its cognitive consequences.
Collapse
|
4
|
|
5
|
Clay F, Howett D, FitzGerald J, Fletcher P, Chan D, Price A. Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review. J Alzheimers Dis 2020; 75:23-43. [PMID: 32280091 PMCID: PMC7306888 DOI: 10.3233/jad-191218] [Citation(s) in RCA: 49] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/13/2020] [Indexed: 12/26/2022]
Abstract
BACKGROUND Immersive virtual reality (iVR) allows seamless interaction with simulated environments and is becoming an established tool in clinical research. It is unclear whether iVR is acceptable to people with Alzheimer's disease (AD) dementia or useful in their care. We explore whether iVR is a viable research tool that may aid the detection and treatment of AD. OBJECTIVES This review examines the use of iVR in people with AD or mild cognitive impairment (MCI). METHODS Medline, PsycINFO, Embase, CINAHL, and Web of Science databases were searched from inception. PRISMA guidelines were used with studies selected by at least two researchers. RESULTS Nine studies were eligible for inclusion. None reported any issues with iVR tolerability in participants with MCI and AD on assessment or treatment tasks. One study demonstrated capability for detecting prodromal AD and correlated with neuroanatomical substrates. Two studies showed iVR to have high accuracy in differentiating participants with AD from controls but were not hypothesis driven or with adequate controls measures. In a small validation study and two longitudinal case studies, iVR cognitive training was positively rated but did not demonstrate reliable benefit. CONCLUSION iVR is emerging as a viable method of assessing older adults and people with AD. Strongest benefits were seen when closely integrated with theoretical models of neurodegeneration and existing screening methods. Further randomized controlled trials integrated with clinical populations are required. This will consolidate the power of iVR for assessment of MCI and clarify treatment efficacy beyond current applications in physical rehabilitation.
Collapse
Affiliation(s)
- Felix Clay
- Cambridge and Peterborough Foundation Trust, Elizabeth House, Fulbourn Hospital Cambridge, Cambridge, UK
- ARC East of England, Douglas House, Cambridge, UK
| | - David Howett
- University of Cambridge, Department of Clinical Neurosciences, Cambridge Biomedical Campus, Cambridge, UK
| | - James FitzGerald
- Cambridge and Peterborough Foundation Trust, Elizabeth House, Fulbourn Hospital Cambridge, Cambridge, UK
- ARC East of England, Douglas House, Cambridge, UK
| | - Paul Fletcher
- Cambridge and Peterborough Foundation Trust, Elizabeth House, Fulbourn Hospital Cambridge, Cambridge, UK
- Department of Psychiatry, University of Cambridge, Cambridge, UK
- Wellcome Trust MRC Institute of Metabolic Science, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK
| | - Dennis Chan
- University of Cambridge, Department of Clinical Neurosciences, Cambridge Biomedical Campus, Cambridge, UK
- Institute of Cognitive Neuroscience, University College London, Alexandra House, London, UK
| | - Annabel Price
- Cambridge and Peterborough Foundation Trust, Elizabeth House, Fulbourn Hospital Cambridge, Cambridge, UK
- ARC East of England, Douglas House, Cambridge, UK
| |
Collapse
|
6
|
Mundugaru R, Sivanesan S, Popa-Wagner A, Udaykumar P, Kirubagaran R, KP G, Vidyadhara D. Pluchea lanceolata protects hippocampal neurons from endothelin-1 induced ischemic injury to ameliorate cognitive deficits. J Chem Neuroanat 2018; 94:75-85. [DOI: 10.1016/j.jchemneu.2018.09.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2018] [Revised: 09/24/2018] [Accepted: 09/27/2018] [Indexed: 12/23/2022]
|
7
|
Wang S, Zhang J, Sheng T, Lu W, Miao D. Hippocampal ischemia causes deficits in local field potential and synaptic plasticity. J Biomed Res 2015; 29:370-9. [PMID: 26445570 PMCID: PMC4585431 DOI: 10.7555/jbr.29.20150010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2015] [Revised: 03/16/2015] [Accepted: 05/10/2015] [Indexed: 11/16/2022] Open
Abstract
The long-term enhancement in glutamate receptor mediated excitatory responses has been observed in stroke model. This pathological form of plasticity, termed post-ischemic long-term potentiation (i-LTP), points to functional reorganization after stroke. Little is known, however, about whether and how this i-LTP would affect subsequent induction of synaptic plasticity. Here, we first directly confirmed that i-LTP was induced in the endothelin-1-induced ischemia model as in other in vitro models. We also demonstrated increased expression of NR2B, CaMKII and p-CaMKII, which are reminiscent of i-LTP. We further induced LTP of field excitatory postsynaptic potentials (fEPSPs) on CA1 hippocampal neurons in peri-infarct regions of the endothelin-1-induced mini-stroke model. We found that LTP of fEPSPs, induced by high-frequency stimulation, displayed a progressive impairment at 12 and 24 hours after ischemia. Moreover, using in vivo multi-channel recording, we found that the local field potential, which represents electrical property of cell ensembles in more restricted regions, was also dampened at these two time points. These results suggest that i-LTP elevates the induction threshold of subsequent synaptic plasticity. Our data helps to deepen the knowledge of meta-synaptic regulation of plasticity after focal ischemia.
Collapse
Affiliation(s)
- Shaoli Wang
- The Research Center for Bone and Stem Cells, Department of Human Anatomy
| | - Jingyun Zhang
- The Key Laboratory of Developmental Genes and Human Disease, Institute of Life Sciences, Southeast University , Nanjing, Jiangsu 210096 , China
| | - Tao Sheng
- The Center of Metabolic Disease Research, Nanjing Medical University , Nanjing, Jiangsu 210029 , China
| | - Wei Lu
- Department of Neurobiology ; The Key Laboratory of Developmental Genes and Human Disease, Institute of Life Sciences, Southeast University , Nanjing, Jiangsu 210096 , China
| | - Dengshun Miao
- The Research Center for Bone and Stem Cells, Department of Human Anatomy
| |
Collapse
|
8
|
Sheng T, Zhang X, Wang S, Zhang J, Lu W, Dai Y. Endothelin-1-induced mini-stroke in the dorsal hippocampus or lateral amygdala results in deficits in learning and memory. J Biomed Res 2015; 29:362-9. [PMID: 26445569 PMCID: PMC4585430 DOI: 10.7555/jbr.29.20150008] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2015] [Revised: 03/29/2015] [Accepted: 04/27/2015] [Indexed: 11/08/2022] Open
Abstract
Functional and structural alterations in brain connectivity associated with brain ischemia have been extensively studied. However, the mechanism whereby local ischemia in deep brain region affect brain functions is still unknown. Here, we first established a mini-stroke model by infusion of endothelin-1 (ET-1) into the dorsal hippocampus or the lateral amygdala, and then investigated how these mini-infarcts affected brain functions associated with these regions. We found that rats with ET-1 infusion showed deficit in recall of contextual fear memory, but not in learning process and recall of tone fear memory. In novel object task, ET-1 in the hippocampus also eliminated object identity memory. ET-1 in the lateral amygdale affected acquisition of fear conditioning and disrupted retention of tone-conditioned fear, but did not impair retention of contextual fear. These findings suggest that ET-1-induced mini-infarct in deep brain area leads to functional deficits in learning and memory associated with these regions.
Collapse
Affiliation(s)
- Tao Sheng
- The Center of Metabolic Disease Research
| | - Xueting Zhang
- The Key Laboratory of Developmental Genes and Human Disease, Institute of Life Sciences, Southeast University , Nanjing, Jiangsu 210096 , China
| | - Shaoli Wang
- The Key Laboratory of Developmental Genes and Human Disease, Institute of Life Sciences, Southeast University , Nanjing, Jiangsu 210096 , China
| | - Jingyun Zhang
- The Key Laboratory of Developmental Genes and Human Disease, Institute of Life Sciences, Southeast University , Nanjing, Jiangsu 210096 , China
| | - Wei Lu
- Department of Neurobiology, Nanjing Medical University , Nanjing, Jiangsu 210029 , China ; The Key Laboratory of Developmental Genes and Human Disease, Institute of Life Sciences, Southeast University , Nanjing, Jiangsu 210096 , China
| | - Yifan Dai
- The Center of Metabolic Disease Research
| |
Collapse
|